X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 M | 2025-12-22 | WHF | Whitehorse Finance, Inc. | Closed-End Funds | 2 | P - Purchase | $6.89 | +59,300 | 315,830 | +23% | +$408,344 | |||||
| 6 | 2025-12-18 | COO | Cooper Companies, Inc. | Ophthalmic Goods | 5 | P - Purchase | $80.00 | +18,014 | 303,566 | +6% | +$1,441,196 | |||||
| 6 M | 2025-12-19 | DMLP | Dorchester Minerals, L.P. | Crude Petroleum & Natural Gas | 5 | P - Purchase | $22.06 | +51,143 | 804,432 | +7% | +$1,128,326 | |||||
| 3 | 2025-12-19 | BRR | Procap Financial, Inc. | Finance Services | 3 | P - Purchase | $3.35 | +336,250 | 836,251 | +67% | +$1,128,088 | |||||
| 3 M | 2025-12-19 | EPSN | Epsilon Energy Ltd. | Crude Petroleum & Natural Gas | 2 | P - Purchase | $4.74 | +62,200 | 982,083 | +7% | +$294,569 | |||||
| 3 | 2025-12-22 | AZO | Autozone Inc | Auto & Home Supply Stores | 3 | P - Purchase | $3,398.43 | +347 | 2,016 | +21% | +$1,179,256 | |||||
| 4 M | 2025-12-18 | VSTS | Vestis Corp | Miscellaneous Nondurable Goods | 4 | P - Purchase | $6.75 | +1,205,810 | 20,824,551 | +6% | +$8,138,830 | |||||
| 8 D | 2025-12-18 | XZO | Exzeo Group, Inc. | Fire, Marine & Casualty Insurance | 8 | P - Purchase | $20.61 | +118,550 | 3,331,383 | +4% | +$2,443,330 | |||||
| 28 M | 2025-12-18 | TPVG | Triplepoint Venture Growth Bdc Corp. | Closed-End Funds | 2 | P - Purchase | $6.32 | +2,007,486 | 3,728,281 | +117% | +$12,690,114 | |||||
| 3 | 2025-12-19 | IMNM | Immunome Inc. | Pharmaceutical Preparations | 2 | P - Purchase | $21.23 | +63,789 | 896,547 | +8% | +$1,353,940 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-12-23 | AMLX | Amylyx Pharmaceuticals, Inc. | Firestone Karen | Dir | P - Purchase | $12.45 | +8,100 | 63,100 | +15% | +$100,845 | ||||||
| M | 2025-12-22 | WHF | Whitehorse Finance, Inc. | Aronson Stuart D | CEO | P - Purchase | $6.86 | +17,000 | 67,000 | +34% | +$116,600 | |||||
2025-12-23 | UPXI | Upexi, Inc. | Marshall Allan | CEO | P - Purchase | $1.80 | +50,000 | 4,046,261 | +1% | +$90,000 | ||||||
| M | 2025-12-18 | SSGC | Safespace Global Corp | Hillis Dustin Michael | Pres, Chief Strat Officer | P - Purchase | $0.25 | +100,000 | 7,354,500 | +1% | +$25,095 | |||||
| M | 2025-12-19 | AGIG | Abundia Global Impact Group, Inc. | Gillespie Edward Oliver | CEO | P - Purchase | $1.85 | +38,461 | 38,461 | New | +$71,261 | |||||
| M | 2025-12-19 | TCRX | Tscan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% | P - Purchase | $0.90 | +161,801 | 15,956,564 | +1% | +$145,526 | |||||
2025-12-23 | ALNT | Allient Inc | Winter Michael R | Dir | P - Purchase | $55.85 | +847 | 39,814 | +2% | +$47,305 | ||||||
| M | 2025-12-19 | GLP | Global Partners LP | Global Gp LLC | General Partner | P - Purchase | $42.84 | +4,330 | 230,273 | +2% | +$185,507 | |||||
| M | 2025-12-19 | SPRU | Spruce Power Holding Corp | Steel Partners Holdings L.P. | 10% | P - Purchase | $5.05 | +17,033 | 3,178,559 | +1% | +$85,989 | |||||
2025-12-22 | ABTC | American Bitcoin Corp. | Busch Richard | Dir | P - Purchase | $1.98 | +101,000 | 1,000,975 | +11% | +$199,980 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-12-23 | UPXI | Upexi, Inc. | Marshall Allan | CEO | P - Purchase | $1.80 | +50,000 | 4,046,261 | +1% | +$90,000 | ||||||
| M | 2025-12-18 | SSGC | Safespace Global Corp | Hillis Dustin Michael | Pres, Chief Strat Officer | P - Purchase | $0.25 | +100,000 | 7,354,500 | +1% | +$25,095 | |||||
| M | 2025-12-19 | AGIG | Abundia Global Impact Group, Inc. | Gillespie Edward Oliver | CEO | P - Purchase | $1.85 | +38,461 | 38,461 | New | +$71,261 | |||||
| M | 2025-12-19 | TCRX | Tscan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% | P - Purchase | $0.90 | +161,801 | 15,956,564 | +1% | +$145,526 | |||||
2025-12-22 | ABTC | American Bitcoin Corp. | Busch Richard | Dir | P - Purchase | $1.98 | +101,000 | 1,000,975 | +11% | +$199,980 | ||||||
| M | 2025-12-19 | GPUS | Hyperscale Data, Inc. | Ault Milton C III | Exec COB, 10% | P - Purchase | $0.23 | +315,000 | 975,671 | +48% | +$73,323 | |||||
2025-12-19 | BMNM | Bimini Capital Management, Inc. | Dwyer Robert J | Dir, 10% | P - Purchase | $1.55 | +100,000 | 1,476,339 | +7% | +$155,000 | ||||||
2025-12-23 | ALT | Altimmune, Inc. | Gill John | Dir | P - Purchase | $4.10 | +12,500 | 12,500 | New | +$51,250 | ||||||
2025-12-19 | BMNM | Bimini Capital Management, Inc. | Cauley Robert E | CEO, 10% | P - Purchase | $1.55 | +192,248 | 1,560,215 | +14% | +$297,984 | ||||||
2025-12-19 | BMNM | Bimini Capital Management, Inc. | Haas G Hunter IV | CFO, 10% | P - Purchase | $1.55 | +192,247 | 1,491,517 | +15% | +$297,983 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-22 | IONQ | Ionq, Inc. | Chou Kathryn K. | Dir | S - Sale+OE | $55.00 | -5,000 | 60,839 | -8% | -$275,000 | |||||
| D | 2025-12-22 | ONDS | Ondas Holdings Inc. | Sood Jaspreet K | Dir | S - Sale+OE | $9.48 | -29,698 | 217,622 | -12% | -$281,537 | |||||
| D | 2025-12-22 | ONDS | Ondas Holdings Inc. | Seidl Randy | Dir | S - Sale+OE | $9.48 | -21,520 | 260,656 | -8% | -$204,010 | |||||
| D | 2025-12-22 | ONDS | Ondas Holdings Inc. | Cohen Richard M | Dir | S - Sale+OE | $9.48 | -25,861 | 242,657 | -10% | -$245,162 | |||||
| D | 2025-12-19 | OLMA | Olema Pharmaceuticals, Inc. | Clark Ian T | Dir | S - Sale+OE | $29.73 | -264,800 | 0 | -100% | -$7,873,109 | |||||
2025-12-19 | OLMA | Olema Pharmaceuticals, Inc. | Myles David C. | CH. DISCOV., NON-CLIN DEV OFF | S - Sale | $30.46 | -51,000 | 710,558 | -7% | -$1,553,544 | ||||||
| DM | 2025-12-19 | OLMA | Olema Pharmaceuticals, Inc. | Zojwalla Naseem | Chief Medical Officer | S - Sale+OE | $27.94 | -269,509 | 4,488 | -98% | -$7,530,148 | |||||
| D | 2025-12-19 | TPB | Turning Point Brands, Inc. | Glazek David Edward | Exec COB | S - Sale+OE | $110.26 | -30,000 | 127,083 | -19% | -$3,307,800 | |||||
2025-12-22 | OKLO | Oklo Inc. | Cochran Caroline | Co-Founder, COO, 10% | S - Sale | $82.32 | -840,000 | 22,442,206 | -4% | -$69,150,555 | ||||||
2025-12-22 | OKLO | Oklo Inc. | Dewitte Jacob | Co-Founder, CEO, 10% | S - Sale | $82.32 | -840,000 | 22,442,206 | -4% | -$69,150,555 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-22 | IONQ | Ionq, Inc. | Chou Kathryn K. | Dir | M - OptEx | $4.61 | +5,000 | 60,839 | +9% | +$23,050 | |||||
| D | 2025-12-22 | IONQ | Ionq, Inc. | Chou Kathryn K. | Dir | S - Sale+OE | $55.00 | -5,000 | 60,839 | -8% | -$275,000 | |||||
| D | 2025-12-22 | ONDS | Ondas Holdings Inc. | Sood Jaspreet K | Dir | S - Sale+OE | $9.48 | -29,698 | 217,622 | -12% | -$281,537 | |||||
| D | 2025-12-22 | ONDS | Ondas Holdings Inc. | Seidl Randy | Dir | S - Sale+OE | $9.48 | -21,520 | 260,656 | -8% | -$204,010 | |||||
| D | 2025-12-22 | ONDS | Ondas Holdings Inc. | Cohen Richard M | Dir | S - Sale+OE | $9.48 | -25,861 | 242,657 | -10% | -$245,162 | |||||
| D | 2025-12-22 | ONDS | Ondas Holdings Inc. | Laird Neil J | CFO, Secretary, Treasurer | S - Sale+OE | $9.48 | -4,526 | 13,393 | -25% | -$42,906 | |||||
2025-12-22 | WS | Worthington Steel, Inc. | Gilmore Geoffrey G | Pres, CEO | F - Tax | $36.32 | -9,610 | 305,017 | -3% | -$349,035 | ||||||
| D | 2025-12-19 | OLMA | Olema Pharmaceuticals, Inc. | Clark Ian T | Dir | M - OptEx | $4.61 | +264,800 | 0 | -100% | +$1,219,544 | |||||
| D | 2025-12-19 | OLMA | Olema Pharmaceuticals, Inc. | Clark Ian T | Dir | S - Sale+OE | $29.73 | -264,800 | 0 | -100% | -$7,873,109 | |||||
2025-12-19 | OLMA | Olema Pharmaceuticals, Inc. | Myles David C. | CH. DISCOV., NON-CLIN DEV OFF | S - Sale | $30.46 | -51,000 | 710,558 | -7% | -$1,553,544 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |